Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

Summary

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmatic participants with type 2 inflammation, characterized by an eosinophilic phenotype.

Timeline

Start

2024-07-19

Primary completion

2028-01-05

Completion

2028-02-11

Drugs

Indications